Serbia's Torlak Institute of Virology, Vaccines and Sera signed a contract on Monday on technology's transfer with the Russian Fund for Direct Investments and the Generium pharmaceutical company to start the production of the Sputnik V vaccine in the country, Nenad Popovic, Minister without portfolio in charge of innovations and technological development, said. Pročitaj više